연구성과로 돌아가기
2024 연구성과별 연구자 정보 (446 / 2344)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Comparison of Recombinant Human Thyroid-Stimulating Hormone and Thyroid Hormone Withdrawal for ¹³¹I Therapy in Patients With Intermediate- to High-Risk Thyroid Cancer | Seo, Youngduk | Seo, Y | 4 | Chungnam Natl Univ, Sejong Hosp, Dept Nucl Med, Sejong, South Korea | 0000-0002-9779-9060 | Seo, Youngduk | arieshamal@snu.ac.kr;bangjiin@gmail.com;mdbabyduck@gmail.com;arichong.md@gmail.com;cmhong@knu.ac.kr;dong-eun@ncc.re.kr;mychoi@neca.re.kr;swleenm@knu.ac.kr;mdosw@snu.ac.kr; | |||
| Comparison of Recombinant Human Thyroid-Stimulating Hormone and Thyroid Hormone Withdrawal for ¹³¹I Therapy in Patients With Intermediate- to High-Risk Thyroid Cancer | Chong, Ari | Chong, A | 5 | Chosun Univ Hosp, Dept Nucl Med, Gwangju, South Korea | arieshamal@snu.ac.kr;bangjiin@gmail.com;mdbabyduck@gmail.com;arichong.md@gmail.com;cmhong@knu.ac.kr;dong-eun@ncc.re.kr;mychoi@neca.re.kr;swleenm@knu.ac.kr;mdosw@snu.ac.kr; | |||||
| Comparison of Recombinant Human Thyroid-Stimulating Hormone and Thyroid Hormone Withdrawal for ¹³¹I Therapy in Patients With Intermediate- to High-Risk Thyroid Cancer | Chong, Ari | Chong, A | 5 | Coll Med, Gwangju, South Korea | arieshamal@snu.ac.kr;bangjiin@gmail.com;mdbabyduck@gmail.com;arichong.md@gmail.com;cmhong@knu.ac.kr;dong-eun@ncc.re.kr;mychoi@neca.re.kr;swleenm@knu.ac.kr;mdosw@snu.ac.kr; | |||||
| Comparison of Recombinant Human Thyroid-Stimulating Hormone and Thyroid Hormone Withdrawal for ¹³¹I Therapy in Patients With Intermediate- to High-Risk Thyroid Cancer | Hong, Chae Moon | Hong, CM | 6 | Kyungpook Natl Univ, Sch Med, Dept Nucl Med, Daegu, South Korea | 0000-0002-5519-6982 | Hong, Chae Moon | arieshamal@snu.ac.kr;bangjiin@gmail.com;mdbabyduck@gmail.com;arichong.md@gmail.com;cmhong@knu.ac.kr;dong-eun@ncc.re.kr;mychoi@neca.re.kr;swleenm@knu.ac.kr;mdosw@snu.ac.kr; | |||
| Comparison of Recombinant Human Thyroid-Stimulating Hormone and Thyroid Hormone Withdrawal for ¹³¹I Therapy in Patients With Intermediate- to High-Risk Thyroid Cancer | Lee, Dong-Eun | Lee, DE | 7 | Natl Canc Ctr, Biostat Collaborat Team, Goyang, South Korea | arieshamal@snu.ac.kr;bangjiin@gmail.com;mdbabyduck@gmail.com;arichong.md@gmail.com;cmhong@knu.ac.kr;dong-eun@ncc.re.kr;mychoi@neca.re.kr;swleenm@knu.ac.kr;mdosw@snu.ac.kr; | |||||
| Comparison of Recombinant Human Thyroid-Stimulating Hormone and Thyroid Hormone Withdrawal for ¹³¹I Therapy in Patients With Intermediate- to High-Risk Thyroid Cancer | Choi, Miyoung | Choi, M | 8 | Div Healthcare Technol Assessment Res, Natl Evidence Based Healthcare Collaborating Agcy, Seoul, South Korea | arieshamal@snu.ac.kr;bangjiin@gmail.com;mdbabyduck@gmail.com;arichong.md@gmail.com;cmhong@knu.ac.kr;dong-eun@ncc.re.kr;mychoi@neca.re.kr;swleenm@knu.ac.kr;mdosw@snu.ac.kr; | |||||
| Comparison of Recombinant Human Thyroid-Stimulating Hormone and Thyroid Hormone Withdrawal for ¹³¹I Therapy in Patients With Intermediate- to High-Risk Thyroid Cancer | Lee, Sang-Woo | Lee, SW | 9 | Kyungpook Natl Univ, Sch Med, Dept Nucl Med, Daegu, South Korea | KUD-1906-2024 | lee, sangwoo | arieshamal@snu.ac.kr;bangjiin@gmail.com;mdbabyduck@gmail.com;arichong.md@gmail.com;cmhong@knu.ac.kr;dong-eun@ncc.re.kr;mychoi@neca.re.kr;swleenm@knu.ac.kr;mdosw@snu.ac.kr; | |||
| Comparison of Recombinant Human Thyroid-Stimulating Hormone and Thyroid Hormone Withdrawal for ¹³¹I Therapy in Patients With Intermediate- to High-Risk Thyroid Cancer | Lee, Sang-Woo | Lee, SW | 9 | Chilgok Hosp, Daegu, South Korea | KUD-1906-2024 | lee, sangwoo | arieshamal@snu.ac.kr;bangjiin@gmail.com;mdbabyduck@gmail.com;arichong.md@gmail.com;cmhong@knu.ac.kr;dong-eun@ncc.re.kr;mychoi@neca.re.kr;swleenm@knu.ac.kr;mdosw@snu.ac.kr; | |||
| Comparison of Recombinant Human Thyroid-Stimulating Hormone and Thyroid Hormone Withdrawal for ¹³¹I Therapy in Patients With Intermediate- to High-Risk Thyroid Cancer | Oh, So Won | Oh, SW | 10 | 교신저자 | Seoul Natl Univ, Boramae Med Ctr, Dept Nucl Med, 20 Boramae Ro 5 Gil, Seoul 07061, South Korea | arieshamal@snu.ac.kr;bangjiin@gmail.com;mdbabyduck@gmail.com;arichong.md@gmail.com;cmhong@knu.ac.kr;dong-eun@ncc.re.kr;mychoi@neca.re.kr;swleenm@knu.ac.kr;mdosw@snu.ac.kr; | ||||
| Comparison of Short-Term Outcomes and Safety Profiles between Androgen Deprivation Therapy plus Abiraterone/Prednisone and Androgen Deprivation Therapy plus Docetaxel in Patients with De Novo Metastatic Hormone-Sensitive Prostate Cancer | Park, Dong Jin | Park, DJ | 1 | Dongguk Univ, Coll Med, Dept Urol, Gyeongju, South Korea | 0000-0003-1667-2146 | Park, Dong Jin | skhwan.script@gmail.com; | |||
| Comparison of Short-Term Outcomes and Safety Profiles between Androgen Deprivation Therapy plus Abiraterone/Prednisone and Androgen Deprivation Therapy plus Docetaxel in Patients with De Novo Metastatic Hormone-Sensitive Prostate Cancer | Kwon, Tae Gyun | Kwon, TG | 2 | Kyungpook Natl Univ, Sch Med, Dept Urol, Daegu, South Korea | 0000-0002-4390-0952 | KWON, TAE GYUN | skhwan.script@gmail.com; | |||
| Comparison of Short-Term Outcomes and Safety Profiles between Androgen Deprivation Therapy plus Abiraterone/Prednisone and Androgen Deprivation Therapy plus Docetaxel in Patients with De Novo Metastatic Hormone-Sensitive Prostate Cancer | Park, Jae Young | Park, JY | 3 | Korea Univ, Ansan Hosp, Dept Urol, Ansan, South Korea | AFQ-0813-2022 | Park, Jae Young | 0000-0002-6664-6846 | Park, Jae young | skhwan.script@gmail.com; | |
| Comparison of Short-Term Outcomes and Safety Profiles between Androgen Deprivation Therapy plus Abiraterone/Prednisone and Androgen Deprivation Therapy plus Docetaxel in Patients with De Novo Metastatic Hormone-Sensitive Prostate Cancer | Joung, Jae Young | Joung, JY | 4 | Natl Canc Ctr, Ctr Prostate Canc, Dept Urol, Goyang, South Korea | skhwan.script@gmail.com; | |||||
| Comparison of Short-Term Outcomes and Safety Profiles between Androgen Deprivation Therapy plus Abiraterone/Prednisone and Androgen Deprivation Therapy plus Docetaxel in Patients with De Novo Metastatic Hormone-Sensitive Prostate Cancer | Ha, Hong Koo | Ha, HK | 5 | Pusan Natl Univ, Pusan Natl Univ Hosp, Sch Med, Dept Urol, Busan, South Korea | W-1873-2019 | Ha, Hong | skhwan.script@gmail.com; | |||
| Comparison of Short-Term Outcomes and Safety Profiles between Androgen Deprivation Therapy plus Abiraterone/Prednisone and Androgen Deprivation Therapy plus Docetaxel in Patients with De Novo Metastatic Hormone-Sensitive Prostate Cancer | Jeon, Seong Soo | Jeon, SS | 6 | Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Urol, Seoul, South Korea | skhwan.script@gmail.com; |
페이지 이동: